Top 50 Most Viewed Posts Last Week |
Today This Week Last Week This Month Last Month
|
1. MJS719: Happy New Year to all. Just saw this and wanted (1949) (13) |
2. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1355) |
3. mightycydy: Bill Gates mentions accelerated rollout of HIV (1230) (33) |
4. mountaineer: If (rather when) we get back to $1.00 it will be (987) (7) |
5. sean007: About seven months ago Novo Nordisk announced a (893) (7) |
6. Shredbull23: Exactly armysqueal is nothing but a loud mouth (872) (6) |
7. Katangolo: First page: “Other Receivables (Note 9) $2M Is (866) (4) |
8. dfwl28: My comment to NY Times article on pain. (813) (18) |
9. Enjay: I thought the uptick in M&A activity in the (804) (9) |
10. docj: MGK_2's latest from Reddit: (771) (11) |
11. Figgs: I am guessing we get news before chaos hits the (726) (10) |
12. misiu143: Alz pilot study is 3 months 20 patients trial. (722) (24) |
13. Drano: Volume 1,246,159 one hour before the close. Let's (690) |
14. Shelly2626: We r so reddy Damn let's go (689) (7) |
15. biloxiblues: I was visiting with AI ChatGPT this morning, and (683) (5) |
16. Evil Rabbit: To those who asked… thanks! I’m in a part of (674) (22) |
17. mightycydy: To answer your question, that article is (668) (16) |
18. BZE: I agree. I think a MASH licensing or partnership (660) (10) |
19. Drano: Well, who knows. I also got a notification that (633) (1) |
20. Drano: "Nader's three-digit promised land." It occurs to (619) (4) |
21. cardamine: Reminds me of decades-ago Congressional testimony (612) (5) |
22. Nt2innvovate: Ohm. When you get a chance. Take a look at (608) (3) |
23. Riztheinvestor: The 10-Q isn’t relevant to the recent slight (604) (6) |
24. MGK_2: In the linked post written 10/26/2024 with over (603) (7) |
25. mightycydy: CYDY's Dr. Scott Hansen & The Gates Foundation (602) (15) |
26. Parrothead47: Anyone ever look at Schwab "technicals"? Todays (602) (12) |
27. KenChowder: The company communications that caused this rise (596) (15) |
28. docj: 10Q (594) (2) |
29. Charter2024: This is moving....and into (589) (2) |
30. mdillon: Earnings: There is nothing on the website about (588) |
31. docj: Last year it was 1/16 not that it makes any (588) |
32. mightycydy: Regarding your question about "proof of (583) (19) |
33. ScottyDoggs: I read all of comments made but to remember what (574) (6) |
34. mountaineer: “None of the above should be taken as (573) (4) |
35. sean007: Seems as good a place as anything else...a (560) (4) |
36. docj: More from MGK_2 on Reddit: (549) (5) |
37. misiu143: Great question.. Primary endpoints are (544) (11) |
38. misiu143: I am sure Dr Lalezari investigated what to pick (540) (7) |
39. USS JOHNSTON: Thank You, Mighty! From your OHSU link - "This (538) (8) |
40. sean007: "One relevant PR...WILL change (537) (11) |
41. sean007: I sure hope she felt better....after being (533) (1) |
42. Figgs: Yes, Novo Nordisk is interesting, they came up (531) (3) |
43. cardamine: She wasn't comforted. I think it was her (531) (1) |
44. bugeater: Professor Ohm, was listening to a lecture on (526) (2) |
45. USS JOHNSTON: Thanks, Misiu! I have a question about the Alz (507) (3) |
46. Drano: Just wait until you get an email from the (506) (3) |
47. cardamine: (tried to edit the earlier post -- but time ran (505) (1) |
48. Riztheinvestor: Yup doesn’t appear that many shares out there (494) (1) |
49. docj: They are looking for 100 share lots. I saved Ken (492) (2) |
50. seemingly-harmless: crazy that caplyta could bring in that much money (484) (6) |